Finance

Morgan Stanley: Sodium‑ion Batteries Could Be the 'New Oil'

Morgan Stanley has framed sodium‑ion batteries as a potential “New Oil Age,” projecting rapid adoption and large capital flows as the technology challenges lithium‑based storage. The bank pegs sodium‑ion at 2% of global deployment next year rising to 20% by 2030 and 37% by 2035, and forecasts roughly $800 billion of new investment by 2035—claims that carry material uncertainty and limited independent verification.

Morgan Stanley: Sodium‑ion Batteries Could Be the 'New Oil'

Key Takeaways

  • Morgan Stanley forecasts sodium‑ion will rise from about 2% next year to 20% of global battery deployments by 2030 and 37% by 2035.
  • Global sodium‑ion capacity is projected at 830 GWh in 2030 and 2.4 TWh by 2035, per the bank's report.
  • The bank says sodium‑ion cells can be 30%–40% cheaper than lithium iron phosphate (LFP) variants and perform better in cold weather.
  • Morgan Stanley estimates roughly $800 billion of new investment into sodium‑ion capacity by 2035, creating potential winners across battery makers, auto OEMs, and salt suppliers.
  • Morgan Stanley highlights General Motors’ claimed U.S. manufacturing rights with Peak Energy as a near‑term catalyst, though that specific claim lacks independent verification.

People Involved

  • Jack LuAnalyst, Morgan Stanley
  • Andrew PercocoAnalyst, Morgan Stanley

Entities Involved

  • Morgan StanleyInvestment bank issuing the sodium‑ion adoption and investment forecasts
  • General Motors (GM)Automaker cited as having claimed U.S. manufacturing arrangement for sodium‑ion cells
  • Peak EnergyDeveloper/partner associated with sodium‑ion cell technology linked to GM in reports

MarketMoodz Analysis

If Morgan Stanley’s numbers hold, sodium‑ion would reshape battery capex and raw‑material flows. A jump to 830 GWh by 2030 and 2.4 TWh by 2035 implies heavy factory builds and roughly $800 billion of investment—meaning potential upside for cell manufacturers that can scale, automakers that secure supply, and suppliers of feedstock such as industrial salts. For investors, that translates into new equity plays (battery makers, OEMs like GM, and component suppliers), plus the possibility of a commodity‑style thesis around salt producers and logistics businesses exposed to industrial salt demand.

The bank’s framing sits next to familiar transitions in energy storage: lithium‑ion went from niche to dominant as costs fell and scale rose, and LFP cells became competitive on price and safety for many applications. Morgan Stanley argues sodium‑ion adds a cost and cold‑weather advantage versus LFP—30%–40% cheaper, the bank says—but the claim depends on manufacturing yields, cell chemistry variations and the maturity of supply chains. Key differences from prior shifts: sodium uses abundant feedstocks and leans on established salt markets (de‑icing, water treatment, chemicals, agriculture), which could blunt raw‑material bottlenecks that plagued earlier transitions—but also introduces different industrial exposures and geopolitical considerations.

Watch for verification and execution. The headline numbers come from Morgan Stanley and carry medium confidence; specific claims such as GM’s exclusive U.S. manufacturing rights with Peak Energy carry low confidence and are not independently confirmed. Investors should monitor announced capacity projects, firm cell supply agreements, capex timelines, and salt market dynamics; government incentives for domestic battery production; and real‑world performance data from pilot deployments. Those checkpoints will determine whether sodium‑ion is an industry‑reshaping opportunity or a complementary niche within broader battery markets.

See the mood, every market morning

Get the Dip Buyer's Checklist — the 10 checks before you buy any dip — plus the free Morning Mood email: the market's fear/greed gauge and one name off the Oversold Board, before the open.

Get the free checklist + daily email

Want the whole Board? See the Dip Buyer's Edge →

This article is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.